Zhejiang Cheng Yi Pharmaceutical Co., Ltd.: what insiders have been doing
Insider filings for Zhejiang Cheng Yi Pharmaceutical Co., Ltd. are scarce in the SSE / SZSE (CSRC) feed, the latest one published on 29 September 2026. This page will fill in as new trades are disclosed. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€167,988
1 ops. · all time
Who traded when
BuySale
吕孙战1 sale
Nov 24May 25Nov 25May 26
Top signal score 19 of 100
Buys n/a€167,988 Sells
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 1,697 of 24,148 companies
76.7
score / 100
Value
69
Quality
85
FCF yld7.6%
Earn yld6.3%
EV/EBITDA9.7x
ROE13%
Gross mgn70%
Net mgn24%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
183,789 shares@ CN¥53.1351100.0% of flowA股XSHGSSE:273000001609500670
1 of 1 declaration
About Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
Chengyi Pharmaceutical is a company listed on the Shanghai Stock Exchange, specializing in the production and distribution of pharmaceutical products. It focuses on innovation and the development of medications to improve public health.